Clinical impact of concurrent autologous adoptive T cells immunotherapy in active COVID-19 infected cancer patients for chemotherapy

Clinical impact of concurrent autologous adoptive T cells immunotherapy in active COVID-19 infected cancer patients for chemotherapy

Abstract Background The concurrent presence of COVID-19 infection in advanced cancer patients has increased the mortality since the compromised immunity was inevitably worsen. The role and clinical impact of autologous adoptive T cell immunotherapy (ACT) designed for anti-cancer treatment were not k...

Full description

Saved in:
Bibliographic Details
Main Authors: Congcong Li, Dazhao Xu, Linyao Lu, Shu Peng, Haiyang Zhao, Chuxiong Zeng, Lina Hu, Xianzhi Guo, Li Liu, Feifei Huo, Xiumei Rong, Zhenying Geng, Ping Lin, Xinna Zhou, Xiaoli Wang, Amy Hobeika, Michael A. Morse, Herbert Kim Lyerly, Jun Ren
Format: Article
Language:English
Published: BMC 2025-04-01
Series:Infectious Agents and Cancer
Subjects:
Autologous adoptive cellular immunotherapy
COVID-19 infection
Safety.
Online Access:https://doi.org/10.1186/s13027-025-00654-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13027-025-00654-2

Similar Items